Overview

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
A phase1 study to demonstrate [68Ga]P15-041 binding to bone metastases in prostate cancer and determination of human dosimetry.
Phase:
Early Phase 1
Details
Lead Sponsor:
Five Eleven Pharma, Inc.